Announced on April 5, Medegen is CareFusion’s initial acquisition since the company’s spinoff from Cardinal Health. The acquisition helps the company’s previously announced strategy of acquiring companies or systems complementary to its market leading infusion, respiratory, dispensing and surgical items businesses that meet its objectives of driving innovation and global growth.. CareFusion acquires Medegen for $225M CareFusion , a leading, global medical device business, announced today that it offers completed the acquisition of Medegen, a respected innovator in clinically differentiated needleless access connectors and administration pieces that deliver intravenous medication to individuals, for $225 million in cash.Dennis. ‘The existing guidelines have suggested that IPC is highly recommended only where bloodstream thinning injections are unsuccessful or inappropriate, but this research shows that IPC should be used in all patients at high risk of DVT.’ ‘The results from the CLOTS 3 study are really groundbreaking, ‘ said Mark A. Turco, MD, Chief Medical Officer, Vascular Therapies, Covidien. ‘The huge, statistically significant mortality decrease in stroke individuals treated with sequential compression versus routine care, along with the near 30 percent reduction in proximal DVT, should revolutionize post-stroke treatment leading to improved patient outcomes.’.. Animal populations decline worldwide rapidly, many amphibians about the verge of extinction A new study posted in the journal Annals of the New York Academy of Sciences probes the issue of why animal populations around the world are quickly diminishing, and shows that a variety of factors is to be blamed for the particularly high loss of life rates among amphibians.